Tag: Novo
Cash pay is ‘going to constitute a major part of the Wegovy business’: Novo Nordisk CFO
Novo Nordisk (NVO) faced a setback with an earnings miss, causing a 4% drop in its stock price.…
Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales
Novo Nordisk (NVO) stock took a hit in pre-market trading after the company reported a miss on both…
Novo Nordisk shares plummet as 2025 guidance is cut, overshadowing new CEO
Novo Nordisk, a major player in the pharmaceutical industry, has recently faced setbacks that have led to a…
UnitedHealth, Novo Nordisk, Covid vaccines
Good morning to all readers! One of the perks of having a library card is the ability to…
Novo Nordisk chief Jørgensen to step down
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…
Is Novo Nordisk (NVO) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?
Jim Simons, the renowned billionaire investor and mathematician, is famously known as the "Quant King" of hedge funds…
Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this…
Novo Nordisk Forges Multiple Partnerships To Sell Wegovy At A Discount
Novo Nordisk's Multi-Pronged Strategy to Regain Market Share in Obesity Drug Market The pharmaceutical firm Novo Nordisk is…
Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
Novo Nordisk has announced that it will be offering its obesity drug Wegovy directly to patients at a…
Novo Nordisk’s Ozempic and Wegovy, long in shortage, now available
Novo Nordisk's popular diabetes and obesity medications, Ozempic and Wegovy, have been listed on the Food and Drug…